Gerald D. Cagle, Director at AERIE PHARMACEUTICALS INC (AERI), bought 5,622 shares at $25.60 ($100K) on 2015-02-04, disclosed to the SEC on 2016-04-26.
Open-market purchase of $100k AERI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.60 | 500 | $13K | 12.7% |
| 2 | $24.54 | 500 | $12K | 12.2% |
| 3 | $16.31 | 100 | $2K | 1.6% |
| 4 | $16.34 | 100 | $2K | 1.6% |
| 5 | $16.35 | 100 | $2K | 1.6% |
| 6 | $16.39 | 846 |
| $14K |
| 13.8% |
| 7 | $15.46 | 500 | $8K | 7.7% |
| 8 | $15.46 | 500 | $8K | 7.7% |
| 9 | $16.60 | 476 | $8K | 7.9% |
| 10 | $16.60 | 476 | $8K | 7.9% |
| 11 | $16.60 | 1,524 | $25K | 25.2% |
| Total | $17.86 avg | 5,622 | $100K | 100% |
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |